Bibliography
- WINSLOW RM: Hemoglobin-based Red Cell Substitutes, First Edition. Baltimore and London, The Johns Hopkins Univer-sity Press (1992).
- DRACKER RA: The development and use of oxygen-carrying blood substitutes. Immunol. Invest. (1995) 24:403–410.
- VASSAR MJ, HOLCROFT JW: Use of hypertonic-hyperoncotic fluids for resuscitation of trauma pa-tients. J. Intern. Care Med. (1992) 7:189–198.
- DREES TC: Commercial analysis of blood substitute market. Artificial Blood (1997) 5:21.
- ESTEP TN, BECHTEL MK, BUSH SL et al.: The purification of hemoglobin solutions by heating. In: Progress in Clini-cal and Biological Research. Brewer G (Ed.) Alan R Liss, New York (1989):325–336.
- ESTEP TN, BOBKA EW, EBELING AA et al.: Novel aspects of diaspirin cross-linked hemoglobin synthesis and pu-rification. Biomater. Anil: Organs (1989) 17: 636.
- HAUSER CJ, SHOEMAKER WC: Hemoglobin solutions in the treatment of hemorrhagic shock. Crit. Care Med. (1982) 10:283–287.
- USUBA A, MOTOKI R, SUZUKI K, SAKAGUCHI K, TAKA-HASHI A: Study of effect of the newly developed artifi-cial blood 'Neo Red Cells' on hemodynamics and blood gas transport in canine hemorrhagic shock. Biomater. Anil: Cells Immobilizat. Biotechnol (1992) 20:531–538.
- RABINOVICI R, RUDOLPH AS, LIGLER FS, SMITH EF, FEUERSTEIN G: Biological responses to exchange trans-fusion with liposomal encapsulated hemoglobin. Circ. Shock (1992) 37:124–133.
- HESS JR, MACDONALD VW, WINSLOW RM: Dehydration and shock: an animal model of hemorrhage and resus-citation of battlefield injury. Biomater. Artif Cells Immo-bilizat. Biotechnol (1992) 20:499–502.
- MALCOLM DS, KISSINGER D, GARRIOCH M: Diaspirin cross-linked hemoglobin solution as a resuscitative fluid following severe hemorrhage in the rat. Biomater. Anil: Cells Immobilizat. Biotechnol (1992) 20:495–497.
- NING J, ANDERSON PJ, BIRO GP: Resuscitation of bleddogs with pyridoxalated-polymerized hemoglobin so-lution. Biomater. Anil: Cells Immobilizat. Biotechnol (1992) 20:525–530.
- RABINOVICI R, RUDOLPH AS, FEUERSTEIN G: Characteri-zation of hemodynamic, hematologic and biochemical responses to administration of liposome-encapsulated hemoglobin in the conscious, freely moving rat. Circ. Shock (1989) 29:115–132.
- CHANG TMS: Cross-linked hemoglobins being well into clinical trials, increasing research efforts are now on a second generation red blood cell substitute based on encapsulated hemoglobin. Anil: Cells Blood Subs. Immo-bilizat. Biotech. (1995) 23:257–262.
- SALVEMINI D, RADZISZEWSKI W, KORBUT R, VANE J: Theuse of oxyhemoglobin to explore the events underly-ing inhibition of platelet aggregation induced by NO or NO-donors. Br. J. Pharmacol. (1990) 101:991–995.
- MURAD F, MITTAL CK, ARNOLD WP, KATSUKI S, KIMURAH: Guanylate cyclase activation by azide, nitro com-pounds, nitric oxide, and hydroxyl radical and inhibi-tion by hemoglobin and myoglobin. Adv. Cyclic Nucleotide Res. (1978) 9:145–158.
- MORITA-TSUZUKI Y, HARDEBO JE, BOUSKELA E: Inhibi-tion of nitric oxide synthesis attenuates the cerebral blood flow response to stimulation of postganglionic parasympathetic nerves in the rat. J. Cereb. Blood Flow Metab. (1993) 13:993–997.
- FERNANDEZ N, GARCIA JL, GARCIA-VILLALON AL et al.:Cerebral blood flow and cerebrovascular reactivity af-ter inhibition of nitric oxide synthesis in conscious goats. Br. J. Pharmacol. (1993) 110:428–434.
- JONES CJH, DEFILY DV, PATTERSON JL, CHILIAN WM: Endothelium-dependent relaxation competes with alpha-l-adrenergic and alpha-2-adrenergic constric-tion in the canine epicardial coronary microcircula-tion. Circulation (1993) 87:1246–1274.
- SIGMON DH, CARRETERO OA, BEIERWALTES WH: Renalversus femoral hemodynamic response to endothelium-derived relaxing factor synthesis inhibi-tion. J. Vasc. Res. (1993) 30:218–223.
- HESTER RL, ERASLAN A, SAITO Y: Differences in EDNOcontribution to arteriolar diameters at rest and during functional dilation in striated muscles. Am. J. Physiol. (1993) 265:H146–H151.
- SAITO S, WILSON DA, HANLEY DF, TRAYSTMAN RJ: Nitric oxide synthase does not contribute to cerebral autoregulatory phenomena in anaesthetized dogs. J. Autonom. Nerv. Sys. (1994) 49:S73–S76.
- THIEMERMANN C: The role of the L-arginine: nitric ox-ide pathway in circulatory shock. Adv. Pharmacol. (1994) 28:45–79.
- GULATI A, SEN AP, SHARMA AC, SINGH G: Role of ET andNO in resuscitative effect of diaspirin cross-linked he-moglobin after hemorrhage in rat. Am. J. Physiol. (1997) 273:H827–H836.
- SHARMA AC, SINGH G, GULATI A: Role of NO mechanismin cardiovascular effects of diaspirin cross-linked he-moglobin in anesthetized rats. Am. J. Physiol. (1995) 269:H1379–H1388.
- VANE JR, BOTTING RM: Formation by the endotheliumof prostacyclin, nitric oxide and endothelin. J. Lipid Me-diat. (1993) 6:395–404.
- GULATI A, SRIMAL RC: Endothelin mechanisms in thecentral nervous system: a target for drug development. Drug Dev. Res. (1992) 26:361–387.
- YANAGISAWA M, KURIHARA H, KIMURA S eta].: A novelpotent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 332:411–415.
- MATSUMURA Y, TSUKAHARA Y, KUNINOBU K, TAKAOKAM, MORIMOTO S: Phosphoramidon-sensitive endothelin-converting enzyme in vascular endothelial cells converts big endothelin-1 and big endothelin-3 to their mature form. FEBS Lett. (1992) 305:86–90.
- GULATI A, SINGH G, REBELLO S, SHARMA AC: Effect of di-aspirin crosslinked and stroma-reduced hemoglobin on mean arterial pressure and endothelin-1 concentra-tion in rats. Life Sci. (1995) 56:1433–1442.
- GULATI A, SHARMA AC, SINGH G: Role of endothelin inthe cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Grit. Care Med. (1996) 24:137–147.
- GULATI A, REBELLO S: Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglo-bin. J. Lab. Clin. Med. (1994) 124:125–133.
- SHARMA AC, GULATI A: Yohimbine modulates diaspirin crosslinked hemoglobin-induced systemic hemody-namics and regional circulatory effects. Crit. Care Med. (1995) 23:874–884.
- GULATI A, SHARMA AC: Prazosin blocks the pressor but not the regional circulatory effects of diaspirin crosslinked hemoglobin. Life Sci. (1994) 55:121–130.
- TABUCHI Y, NAKAMARU M, RAKUGI H, NAGANO M, OGI-HARA T: Endothelin enhances adrenergic vasoconstric-tion in perfused rat mesenteric arteries. Biochem. Biophys. Res. Commun. (1989) 159:1304–1308.
- REID JJ, VO PA, LIEU AT, WONG DUSTING HK, RAND MJ: Modulation of norepinephrine-induced vasoconstric-tion by endothelin-1 and nitric oxide in rat tail artery. J. Cardiovasc. Pharmacol (1991) 17 (Suppl. 7):5272–5275.
- WONG DUSTING HK, LA M, RAND MJ: Endothelin-1 en-hances vasoconstrictor responses to sympathetic nerve stimulation and noradrenaline in the rabbit ear artery. Clin. Exp. Pharmacol. Physiol. (1991) 18:131–136.
- YANG MC, YU PC, TU MS et al.: Effects of endothelin andvasopressin on portal pressure of rats. Life Sci. (1990) 46:1929–1936.
- GULATI A, SRIMAL RC: Endothelin antagonizes the hy-potension but potentiates the hypertension induced by clonidine. Eur. J. Pharmacol. (1993) 230:293–300.
- RIOUX F, DRAPEAU G, AUDET R, BURHOP KE, MARCEAUF: Mechanism of the contractile effect of diaspirin-cross-linked hemoglobin in rat isolated aorta strip de-nuded of endothelium as revealed using an oil-immersion procedure. Can. J. Physiol. Pharmacol. (1996) 74:1171–1179.
- PINCEMAIL J, DETRY O, PHILIPPART C et al: Diaspirin crosslinked hemoglobin (DCLIIb) - absence of in-creased free radical generation following administra-tion in a rabbit model of renal ischemia and reperfusion. Free Rad. Biol. Med. (1995) 19:1–9.
- ABASSI Z, KOTOB S, PIERUZZI F et al: Effects of polym-erization on the hypertensive action of diaspirin cross-linked hemoglobin in rats. J. Lab. Clin. Med. (1997) 129:603–610.
- NAKAI K, OHTA T, SAKUMA I et al.: Inhibition ofendothelium-dependent relaxation by hemoglobin in rabbit aortic strips - comparison between acellular he-moglobin derivatives and cellular hemoglobins. J. Car-diovasc. Pharmacol. (1996) 28:115–123.
- WINSLOW RM: Blood substitutes in development. Exp.Opin. Invest. Drugs (1996) 5(10:1443–1452.
- CHATTERJEE R, WELTY EV, WALDER RY et al.: Isolationand characterization of a new hemoglobin derivative cross-linked between a-chains (lysine 991-99 2). J. Biol. Chem. (1986) 261:9929–9937.
- HESS JR, FADARE SO, TOLENTINO LS, BANGAL NR, WINSLOW RM: The intravascular persistence of crosslinked human hemoglobin. In: Progress in Clinical and Biological Research. Alan R Liss (Ed.), New York (1989): 351–357.
- ESTEP TN, GONDER J, BORNSTEIN I, YOUNG S, JOHNSON R: Biological evaluation of diaspirin crosslinked hemo-globin solutions. Biomater. Artif Cells Immobilizat. Bio-technol. (1991) 19:378.
- GONZALEZ P, HACKNEY AC, JONES S et al.: A Phase I/II study of polymerized bovine hemoglobin in adult pa-tients with sickle cell disease not in crisis at the time of study. J. Invest. Med. (1997) 45:258–264.
- KASPER SM, WALTER M, GRUNE F et al:: Effects of ahemoglobin-based oxygen carrier (HBOC-201) on he-modynamics and oxygen transport in patients under-going preoperative hemodilution for elective abdominal aortic surgery. Anaes. Analg. (1996) 83:921–927.
- SILLERUD L, CAPRIHAN A, GORCZYNSKI R et al.: Compari-son of Optro, with whole blood using 31P-NMR spec-troscopy. Artif Blood (1997) 5:69.
- NAGAI K, PERUTZ MF, POYART C: Oxygen binding prop-erties of human mutant hemoglobins synthesized in Escherichia coli. Proc. Natl. Acad. Sci. USA (1985) 82:7252–7255.
- IWASHITA Y: Relationship between chemical proper-ties and biological properties of pyridoxalated hemoglobin-polyoxythylene. Biomater. Artif Cells Im-mobilizat. Biotechnol (1992) 20:299–307.
- CHANG TMS: Recent and future developments in modi-fied hemoglobin and microencapsulated hemoglobin as red blood cell substitutes. Artif Cells Blood Substit. Im-mobil. Biotechnol. (1997) 25:1–24.
- BUCCI E, RAZYNSKA A, KWANSA H et al.: Production andcharacteristics of an infusible oxygen-carrying fluid based on hemoglobin intramolecularly cross-linked with sebacic acid. J. Lab. Clin. Med. (1996) 128:146–153.
- HIRSCH RE, JELICKS LA, WITTENBERG BA et al:: A firstevaluation of the natural high molecular weight poly-meric Lumbricus terrestris hemoglobin as an oxygen carrier. Artif Cells Blood Substit. Immobilizat. Biotechnol. (1997) 25:429–444.
- RUDOLPH AS, CLIFF RO, KLIPPER R, GOINS B, PHILLIPSWT: Circulation persistence and biodistribution of ly-ophilized liposome-encapsulated hemoglobin: an oxygen-carrying resuscitative fluid. Grit. Care Med. (1994) 22:142–150.